Consensus Clariane SE

Equities

CLARI

FR0010386334

Market Closed - Euronext Paris Other stock markets 11:37:25 2024-05-24 am EDT			5-day change	1st Jan Change
3.79 ^EUR	-5.11%		+5.28%	+57.65%

May. 22	CLARIANE : Primed to escape the sectoral ESG mud (con’t)
May. 22	Clariane: opening of a clinic in Salon-de-Provence	CF

Evolution of the average Target Price on Clariane SE

Price target over the last 5 years

History of analyst recommendation changes

a4dedebb8cb9295dfe444fe08c4c3.XGmXH_QQAu38uY79GHjW_H0OGZkwcwCVP85nRlC_fC0.HTP_U7t5UNmY8suuLEjnmDZDL9dWPjPZW5swDAPSE1dlJdtcu0NkhpeA7Q~bab9fc7375b412d6ecca0816c8eb1e8f

Analyst Recommendations on Clariane SE

CLARIANE : Primed to escape the sectoral ESG mud (con’t)	May. 22
CLARIANE : Primed to escape the sectoral ESG mud	May. 21
CLARIANE : An outsized dilution effect now looks unlikely	May. 17
CLARIANE : Integrating the updated issuance terms of planned recaps	May. 17
CLARIANE : Expecting a smaller dilution effect	May. 14
CLARIANE : Expecting a smaller dilution effect	May. 08
CLARIANE : Expecting a smaller dilution effect	Apr. 29
CLARIANE : Reiterated outlook backed by a buoyant Q1	Apr. 26
CLARIANE : Opinion change, from Reduce to Sell	Mar. 22
CLARIANE : Morgan Stanley above 5% threshold	Mar. 07	CF
CLARIANE : Target upgrade by 29.1%	Mar. 01
CLARIANE : On-track asset disposals and maintained recap size (con’t)	Feb. 29
CLARIANE : On-track asset disposals and maintained recap size	Feb. 29
CLARIANE : Opinion change, from Buy to Reduce	Feb. 21
CLARIANE : Target upgrade by 39.0%	Jan. 19
CLARIANE : Target upgrade by 5.6%	Dec. 18
CLARIANE : Maintained negative recommendation	Dec. 01
CLARIANE : Allowing for the €300m recap	Nov. 15
CLARIANE : To be significantly diluted too; what comes next?	Nov. 14
CLARIANE : Target cut by -40.0%	23-10-27
CLARIANE : Further affected by disadvantageous credit conditions and seemingly harder cash generation	23-10-26
CLARIANE : Encouraging-looking momentum; FY guidance reconfirmed	23-07-28
KORIAN : Seemingly back on the right trajectory	23-04-27
KORIAN : Tenable but difficult repercussions remain imminent	23-03-02
KORIAN : Opinion change, from Buy to Add	23-02-23